What sector does Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd (1349) operate in?
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd belongs to the Healthcare sector and operates in the Drug Manufacturers - Specialty & Generic industry.
What is Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd (1349) current stock price?
As of the latest data, Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd stock price is HK$3.48, with a previous close of HK$3.40. Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd gained HK$0.08 in the last trading session, representing a 2.35% increase.
What is Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd (1349) current market capitalization?
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd market cap is approximately 1.18 billion.
What is Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd (1349) Earnings Per Share (EPS)?
The trailing EPS is HK$0.04.
What is Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd (1349) Price-to-Earnings (P/E) ratio?
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd current P/E ratio is 83.65.
Does Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd (1349) pay dividends?
Yes. Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd pays semiannual dividends with an annualized yield of 4.35% and an estimated annual payout of HK$0.15 per share.
When is Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd (1349) next earnings report?
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd is expected to release its next earnings report on June 30, 2025.
What is Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd (1349) beta (volatility) score?
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd has a beta of 0.341, indicating lower volatility than the overall market.